P.002 Saccade parameters reveal cognitive impairment and differentially associate with cognitive domains across neurodegenerative diseases
HC Riek,BC Coe,DC Brien,J Huang,A Abrahao,S Arnott,D Beaton,M Binns,S Black,M Borrie,L Casaubon,D Dowlatshahi,E Finger,C Fischer,A Frank,M Freedman,D Grimes,A Hassan,M Jog,S Kumar,D Kwan,A Lang,J Lawrence Dewar,B Levine,W Lou,J Mandzia,C Marras,M Masellis,P McLaughlin,J Orange,S Pasternak,A Peltsch,B Pollock,T Rajji,A Roberts,D Sahlas,G Saposnik,D Seitz,C Shoesmith,T Steeves,S Strother,S Sujanthan,K Sunderland,R Swartz,B Tan,D Tang-Wai,C Tartaglia,A Troyer,J Turnbull,L Zinman,DP Munoz,ONDRI Investigators ()
DOI: https://doi.org/10.1017/cjn.2022.107
2022-06-24
Abstract:Background: Eye movements reveal neurodegenerative disease processes due to overlap between oculomotor circuitry and disease-affected areas. Characterizing oculomotor behaviour in context of cognitive function may enhance disease diagnosis and monitoring. We therefore aimed to quantify cognitive impairment in neurodegenerative disease using saccade behaviour and neuropsychology. Methods: The Ontario Neurodegenerative Disease Research Initiative recruited individuals with neurodegenerative disease: one of Alzheimer's disease, mild cognitive impairment, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's disease, or cerebrovascular disease. Patients (n=450, age 40-87) and healthy controls (n=149, age 42-87) completed a randomly interleaved pro- and anti-saccade task (IPAST) while their eyes were tracked. We explored the relationships of saccade parameters (e.g. task errors, reaction times) to one another and to cognitive domain-specific neuropsychological test scores (e.g. executive function, memory). Results: Task performance worsened with cognitive impairment across multiple diseases. Subsets of saccade parameters were interrelated and also differentially related to neuropsychology-based cognitive domain scores (e.g. antisaccade errors and reaction time associated with executive function). Conclusions: IPAST detects global cognitive impairment across neurodegenerative diseases. Subsets of parameters associate with one another, suggesting disparate underlying circuitry, and with different cognitive domains. This may have implications for use of IPAST as a cognitive screening tool in neurodegenerative disease.
clinical neurology